![](/img/cover-not-exists.png)
Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial
Hulot, Jean-Sébastien, Salem, Joe-Elie, Redheuil, Alban, Collet, Jean-Philippe, Varnous, Shaida, Jourdain, Patrick, Logeart, Damien, Gandjbakhch, Estelle, Bernard, Claude, Hatem, Stéphane N., Isnard,Language:
english
Journal:
European Journal of Heart Failure
DOI:
10.1002/ejhf.826
Date:
April, 2017
File:
PDF, 525 KB
english, 2017